Co-clinical assessment identifies patterns of BRAF inhibitor resistance in melanoma. [electronic resource]
Producer: 20150702Description: 1459-70 p. digitalISSN:- 1558-8238
- Animals
- Antineoplastic Agents -- pharmacology
- Doxycycline -- pharmacology
- Drug Resistance, Neoplasm
- Gene Expression Profiling
- Humans
- Imidazoles -- pharmacology
- Melanoma -- drug therapy
- Melanoma, Experimental -- drug therapy
- Mice
- Neoplasm Proteins -- antagonists & inhibitors
- Oximes -- pharmacology
- PTEN Phosphohydrolase -- physiology
- Protein Kinase Inhibitors -- pharmacology
- Proto-Oncogene Proteins B-raf -- antagonists & inhibitors
- Tamoxifen -- pharmacology
- Transgenes
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.